| Literature DB >> 28438141 |
Devika Iddawela1, Kiruthiha Ehambaram2, Pemindra Bandara2.
Abstract
BACKGROUND: Human toxocariasis, caused by Toxocara canis, T. cati, and T. vitulorum of dogs, cats and ruminants respectively, is recognized as an important zoonotic infection worldwide. The typical clinical syndromes of toxocariasis in humans are ocular larva migrans (OLM) and visceral larva migrans (VLM). The most commonly affected sites of OLM are the peripheral retina and/or vitreous humor. In Sri Lanka, there is a dearth of information on prevalence of ocular infection in our population. Therefore, the present study was carried out to determine the prevalence of Toxocara antibodies in suspected OLM patients and to describe demographic factors and clinical manifestations of seropositive patients. A total of 250 clinically suspected ocular toxocariasis cases referred by consultant eye surgeons to the Department of Parasitology, University of Peradeniya were studied between the years 1995 to April 2015.Entities:
Keywords: ELISA; Ocular larva migrans; Toxocariasis; Vitritis
Mesh:
Substances:
Year: 2017 PMID: 28438141 PMCID: PMC5404299 DOI: 10.1186/s12886-017-0444-0
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Demographic details of participants
| Gender | ||||||||
|---|---|---|---|---|---|---|---|---|
| Male | Female | Unspecified | Total | |||||
| Age group | n | % | n | % | n | % | N | % |
| 0 to 4 | 7 | 5.2 | 10 | 9.1 | 17 | 6.8 | ||
| 5 to 9 | 19 | 14.1 | 7 | 6.4 | 2 | 40 | 28 | 11.2 |
| 10 to 14 | 20 | 14.8 | 19 | 17.3 | 39 | 15.6 | ||
| 15 to 19 | 16 | 11.9 | 9 | 8.2 | 25 | 10 | ||
| 20 to 24 | 8 | 5.9 | 7 | 6.4 | 15 | 6 | ||
| 25 to 29 | 12 | 8.9 | 11 | 10.0 | 23 | 9.2 | ||
| 30 to 34 | 4 | 3.0 | 4 | 3.6 | 8 | 3.2 | ||
| 35 to 39 | 8 | 5.9 | 6 | 5.5 | 14 | 5.6 | ||
| 40 to 44 | 11 | 8.1 | 12 | 10.9 | 23 | 9.2 | ||
| 45 to 49 | 4 | 3.0 | 8 | 7.3 | 12 | 4.8 | ||
| 50 to 54 | 8 | 5.9 | 4 | 3.6 | 12 | 4.8 | ||
| 55 to 59 | 7 | 5.2 | 3 | 2.7 | 10 | 4 | ||
| 60 to 64 | 2 | 1.5 | 0 | 0.0 | 2 | 0.8 | ||
| 65 to 69 | 2 | 1.5 | 3 | 2.7 | 5 | 2 | ||
| 70 to 74 | 2 | 1.5 | 1 | 0.9 | 3 | 1.2 | ||
| 75 to 79 | 1 | 0.7 | 0 | 0.0 | 1 | 0.4 | ||
| Unknown | 4 | 3.0 | 6 | 5.5 | 3 | 60 | 13 | 5.2 |
| Total | 135 | 110 | 5 | 250 | ||||
Prevalence of seropositive males and females in each age group
| Seropositive males | Seropositive female | Total | ||||
|---|---|---|---|---|---|---|
| Age group | N | % | n | % | N | % |
| 0 to 4 | 4 | 4.5 | 3 | 4.5 | 7 | 4.5 |
| 5 to 9 | 14 | 15.7 | 6 | 9.1 | 20 | 12.9 |
| 10 to 14 | 12 | 13.5 | 13 | 19.7 | 25 | 16.1 |
| 15 to 19 | 10 | 11.2 | 6 | 9.1 | 16 | 10.3 |
| 20 to 24 | 5 | 5.6 | 4 | 6.1 | 9 | 5.8 |
| 25 to 29 | 10 | 11.2 | 5 | 7.6 | 15 | 9.7 |
| 30 to 34 | 2 | 2.2 | 1 | 1.5 | 3 | 1.9 |
| 35 to 39 | 4 | 4.5 | 4 | 6.1 | 8 | 5.2 |
| 40 to 44 | 8 | 9.0 | 6 | 9.1 | 14 | 9.0 |
| 45 to 49 | 3 | 3.4 | 6 | 9.1 | 9 | 5.8 |
| 50 to 54 | 6 | 6.7 | 3 | 4.5 | 9 | 5.8 |
| 55 to 59 | 5 | 5.6 | 3 | 4.5 | 8 | 5.2 |
| 60 to 64 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| 65 to 69 | 1 | 1.1 | 2 | 3.0 | 3 | 1.9 |
| 70 to 74 | 2 | 2.2 | 0 | 0.0 | 2 | 1.3 |
| 75 to 79 | 1 | 1.1 | 0 | 0.0 | 1 | 0.6 |
| Unknown | 2 | 2.2 | 4 | 6.1 | 6 | 3.9 |
| Total | 89 | 66 | 155 | |||
Percentage of seronegative and seropositive patients with clinical manifestation
| ELISA positive ( | ELISA negative ( | Total ( | ||||
|---|---|---|---|---|---|---|
| Symptom | Number | % | Number | % | Number | % |
| Retinal leision | 10 | 6.45 | 3 | 3.16 | 13 | 5.2 |
| Choroiditis | 12 | 7.74 | 9 | 9.47 | 21 | 8.4 |
| Uveitis | 53 | 34.19 | 35 | 36.84 | 88 | 35.2 |
| Vitritis | 20 | 12.90 | 2 | 2.11 | 22 | 8.8 |
| Endophthalmitis | 3 | 1.94 | 2 | 2.11 | 5 | 2 |
| Reduced vision | 34 | 21.94 | 18 | 18.95 | 52 | 20.8 |
| Retinal detachment | 5 | 3.23 | 1 | 1.05 | 6 | 2.4 |
| Granuloma | 15 | 9.68 | 7 | 7.37 | 22 | 8.8 |
| Macular scarring | 7 | 4.52 | 9 | 9.47 | 16 | 6.4 |
| Macular coloboma | 1 | 0.65 | 1 | 1.05 | 2 | 0.8 |
| Band keratoma | 1 | 0.65 | 0 | 0.00 | 1 | 0.4 |
| Exudative Retinopathy | 1 | 0.65 | 0 | 0.00 | 1 | 0.4 |
| Macular oedema | 2 | 1.29 | 0 | 0.00 | 2 | 0.8 |
Chi Square analysis
| Symptom | Chi square |
|
|---|---|---|
| Retinal leision | 1.2962 | 0.255 |
| Choroiditis | 0.2296 | 0.632 |
| Uveitis | 0.1811 | 0.67 |
| Vitritis | 8.557 | 0.003 |
| Endophthalmitis | 0.0087 | 0.926 |
| Reduced vision | 0.3192 | 0.572 |
| Retinal detachment | 1.1875 | 0.276 |
| Granuloma | 0.3913 | 0.532 |
| Macular scarring | 2.4165 | 0.12 |
| Macular coloboma | 0.1232 | 0.726 |
| Band keratoma | 0.6154 | 0.433 |
| Exudative retinopathy | 0.6154 | 0.433 |
| Macular oedema | 1.2357 | 0.266 |
P value ≤0.05 was considered to indicate statistical significance